These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10811114)

  • 41. Wortmannin elevates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in LNCaP cells through down-regulation of IAP-2 protein.
    Seol JW; Lee YJ; Kang HS; Kim IS; Kim NS; Kwak YG; Kim TH; Seol DW; Park SY
    Exp Oncol; 2005 Jun; 27(2):120-4. PubMed ID: 15995629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dietary flavonol fisetin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells.
    Szliszka E; Helewski KJ; Mizgala E; Krol W
    Int J Oncol; 2011 Oct; 39(4):771-9. PubMed ID: 21743964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand.
    Jo M; Kim TH; Seol DW; Esplen JE; Dorko K; Billiar TR; Strom SC
    Nat Med; 2000 May; 6(5):564-7. PubMed ID: 10802713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
    Yano K; Horinaka M; Yoshida T; Yasuda T; Taniguchi H; Goda AE; Wakada M; Yoshikawa S; Nakamura T; Kawauchi A; Miki T; Sakai T
    Int J Oncol; 2011 Feb; 38(2):365-74. PubMed ID: 21165560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor necrosis factor-alpha sensitizes prostate cancer cells to gamma-irradiation-induced apoptosis.
    Kimura K; Bowen C; Spiegel S; Gelmann EP
    Cancer Res; 1999 Apr; 59(7):1606-14. PubMed ID: 10197636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
    Yoo J; Park SS; Lee YJ
    J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Szliszka E; Zydowicz G; Janoszka B; Dobosz C; Kowalczyk-Ziomek G; Krol W
    Int J Oncol; 2011 Apr; 38(4):941-53. PubMed ID: 21286663
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
    Qin JZ; Bacon P; Chaturvedi V; Nickoloff BJ
    J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.
    Oya M; Ohtsubo M; Takayanagi A; Tachibana M; Shimizu N; Murai M
    Oncogene; 2001 Jun; 20(29):3888-96. PubMed ID: 11439352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lyssavirus matrix protein induces apoptosis by a TRAIL-dependent mechanism involving caspase-8 activation.
    Kassis R; Larrous F; Estaquier J; Bourhy H
    J Virol; 2004 Jun; 78(12):6543-55. PubMed ID: 15163747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lytic peptide-mediated sensitization of TRAIL-resistant prostate cancer cells to death receptor agonists.
    Barua S; Linton RS; Gamboa J; Banerjee I; Yarmush ML; Rege K
    Cancer Lett; 2010 Jul; 293(2):240-53. PubMed ID: 20347216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells.
    Milani D; Zauli G; Rimondi E; Celeghini C; Marmiroli S; Narducci P; Capitani S; Secchiero P
    J Neurochem; 2003 Jul; 86(1):126-35. PubMed ID: 12807432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.
    Secchiero P; Milani D; Gonelli A; Melloni E; Campioni D; Gibellini D; Capitani S; Zauli G
    J Leukoc Biol; 2003 Aug; 74(2):223-32. PubMed ID: 12885939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. c-Jun N-terminal kinase contributes to apoptotic synergy induced by tumor necrosis factor-related apoptosis-inducing ligand plus DNA damage in chemoresistant, p53 inactive mesothelioma cells.
    Vivo C; Liu W; Broaddus VC
    J Biol Chem; 2003 Jul; 278(28):25461-7. PubMed ID: 12707267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of the NF-kappaB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells.
    Karacay B; Sanlioglu S; Griffith TS; Sandler A; Bonthius DJ
    Cancer Gene Ther; 2004 Oct; 11(10):681-90. PubMed ID: 15332116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.
    Li L; Thomas RM; Suzuki H; De Brabander JK; Wang X; Harran PG
    Science; 2004 Sep; 305(5689):1471-4. PubMed ID: 15353805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycogen synthase kinase-3beta suppression eliminates tumor necrosis factor-related apoptosis-inducing ligand resistance in prostate cancer.
    Liao X; Zhang L; Thrasher JB; Du J; Li B
    Mol Cancer Ther; 2003 Nov; 2(11):1215-22. PubMed ID: 14617795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenovirus-mediated FLT1-targeted proapoptotic gene therapy of human prostate cancer.
    Kaliberov SA; Kaliberova LN; Stockard CR; Grizzle WE; Buchsbaum DJ
    Mol Ther; 2004 Dec; 10(6):1059-70. PubMed ID: 15564138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vanillin enhances TRAIL-induced apoptosis in cancer cells through inhibition of NF-kappaB activation.
    Lirdprapamongkol K; Sakurai H; Suzuki S; Koizumi K; Prangsaengtong O; Viriyaroj A; Ruchirawat S; Svasti J; Saiki I
    In Vivo; 2010; 24(4):501-6. PubMed ID: 20668316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer.
    Wu XX; Kakehi Y; Mizutani Y; Kamoto T; Kinoshita H; Isogawa Y; Terachi T; Ogawa O
    Int J Oncol; 2002 May; 20(5):949-54. PubMed ID: 11956588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.